451 results on '"Nagase, Hiroyuki"'
Search Results
2. Relationship Between Asthma Control Status and Health-Related Quality of Life in Japan: A Cross-Sectional Mixed-Methods Study
3. ZFP36 family expression is suppressed by Th2 cells in asthma, leading to enhanced synthesis of inflammatory cytokines and cell surface molecules
4. Changes in disease burden and treatment reality in patients with severe asthma
5. A splice-switching oligonucleotide treatment ameliorates glycogen storage disease type 1a in mice with G6PC c.648G>T
6. Asthma in an aging world
7. Contributors
8. Questionnaire for diagnosing asthma-COPD overlap in COPD: Development of ACO screening questionnaire (ACO-Q)
9. Biologics for severe asthma: The real-world evidence, effectiveness of switching, and prediction factors for the efficacy
10. Nationwide survey of refractory asthma with bronchiectasis by inflammatory subtypes
11. Relationship between serum IgA levels and low percentage forced expiratory volume in the first second in asthma.
12. [title in Japanese]
13. BASELINE CHARACTERISTICS AND COEXISTING TYPE 2 INFLAMMATORY DISEASES OF PATIENTS WITH ASTHMA INITIATING DUPILUMAB IN A REAL-WORLD SETTING: THE RAPID REGISTRY
14. Japanese guidelines for adult asthma 2020
15. The roles of IL-5 and anti-IL-5 treatment in eosinophilic diseases: Asthma, eosinophilic granulomatosis with polyangiitis, and eosinophilic chronic rhinosinusitis
16. Prevalence, disease burden, and treatment reality of patients with severe, uncontrolled asthma in Japan
17. Pioneering a paradigm shift in asthma management: remission as a treatment goal
18. Review for "Benralizumab in children with severe eosinophilic asthma: Pharmacokinetics and long‐term safety (TATE study)"
19. Comprehensive analysis of allergen-specific IgE in COPD: mite-specific IgE specifically related to the diagnosis of asthma-COPD overlap
20. Severe asthma in Japan
21. Anti–IL-5 treatments in patients with severe asthma by blood eosinophil thresholds: Indirect treatment comparison
22. Pioneering a paradigm shift in asthma management: remission as a treatment goal.
23. A splice-switching oligonucleotide treatment ameliorates glycogen storage disease type 1a with G6PC c.648G>T
24. Baseline serum CXCL10 and IL-12 levels may predict severe asthmatics' responsiveness to omalizumab
25. Association of low-dosage systemic corticosteroid use with disease burden in asthma
26. Contributing factor for the pirfenidone dose reduction in patients with idiopathic interstitial pneumonia in real-world settings—A dose-specific analysis
27. Leukotriene receptor antagonist attenuated airway inflammation and hyperresponsiveness in a double-stranded RNA-induced asthma exacerbation model
28. Japanese guidelines for adult asthma 2017
29. Remission outcomes in severe eosinophilic asthma with mepolizumab therapy: Analysis of the REDES study
30. Toll-like receptor 3 ligand specifically induced bronchial epithelial cell death in caspase dependent manner and functionally upregulated Fas expression
31. A Case of Cerebral Air Embolism During Diagnostic Flexible Bronchoscopy
32. Rapid progress in molecular targeted therapy for allergic diseases
33. Additional file 1 of Nationwide survey of refractory asthma with bronchiectasis by inflammatory subtypes
34. Double inversion recovery imaging of the brain: deriving the most relevant sequence through real images
35. VI．COVID-19と気管支喘息やアレルギー疾患との関わり
36. Reduction in asthma exacerbation rate after mepolizumab treatment initiation in patients with severe asthma: A real-world database study in Japan
37. Targeting Insulin-Like Growth Factor-I in Allergen-Induced Airway Inflammation and Remodeling
38. Chapter 10 - Asthma in an aging world
39. Combined multi-kernel chest computed tomography images optimized for depicting both lung and soft tissue
40. Japanese Guideline for Adult Asthma 2014
41. Diversities of allergic pathologies and their modifiers: Report from the second DGAKI-JSA meeting
42. Establishment of a novel objective and quantitative method to assess pain-related behavior in monosodium iodoacetate-induced osteoarthritis in rat knee
43. Effectiveness of mepolizumab in severe asthma in Japan: A real-world study using claims data
44. Findings of in vitro Analyses of Basophil Functions May Help Us Better Understand Drug Desensitization
45. An Early Intensive Intervention for Inducing Inactive Asthma in Adults —A One-Year Follow-Up Observation Study—
46. The prevalence of comorbid respiratory disease among COVID-19 patients, and mortality during the first wave in Japan: A nationwide survey by the Japanese Respiratory Society
47. The impact of the COVID-19 pandemic on asthma treatment in Japan: Perspectives based on doctors' views
48. Reference Ranges for Exhaled Nitric Oxide Fraction in Healthy Japanese Adult Population
49. Effectiveness of mepolizumab in severe asthma in Japan: A real‐world study using claims data
50. Renadirsen, a Novel 2′OMeRNA/ENA® Chimera Antisense Oligonucleotide, Induces Robust Exon 45 Skipping for Dystrophin In Vivo
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.